# FDA Inspection 1252007 - Janssen Pharmaceuticals Inc. - November 01, 2024

Source: https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/6cf9b413-b5b9-41ea-a1db-605ee18bf2ee
Source feed: FDA_Inspections

> FDA Inspection 1252007 for Janssen Pharmaceuticals Inc. on November 01, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252007
- Company Name: Janssen Pharmaceuticals Inc.
- Inspection Date: 2024-11-01
- Product Type: Biologics
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1225275 - 2023-12-14](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/f5eb5852-3f6a-4246-a387-cf35044c8d21)
- [FDA Inspection 1175643 - 2022-06-17](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/96ba00a9-75a4-42fe-8c7e-317d1ee03074)
- [FDA Inspection 998113 - 2017-01-26](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/b3ea6272-4a0c-4c2c-a92b-37b8191ae003)
- [FDA Inspection 965139 - 2016-01-22](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/b3173e7d-2caa-4560-acd5-80f483d514bf)
- [FDA Inspection 833775 - 2013-05-21](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/7142c62c-b7f3-4997-aa1a-ced0ebfb4d44)

Company: https://www.keypedia.com/companies/janssen-pharmaceuticals-inc/b494dc6e-cfeb-46a2-8c10-e036e6a5a623

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248